Cellebrite DI (NASDAQ:CLBT) Chief Financial Officer David Barter said the company is expanding beyond its roots in mobile device extraction toward a broader digital investigations platform for law enforcement, federal agencies and prosecutors.
Speaking at William Blair & Company’s growth stock conference in a session hosted by analyst Jonathan Ho, Barter described Cellebrite as “a public safety company” focused on helping agencies “protect nations and communities.” He said the company’s roughly 1,300 employees are working to deliver a comprehensive platform that supports evidence collection, investigation, collaboration and AI-assisted analysis.
Cellebrite Emphasizes Platform Expansion
The company has since added a cloud-based collections platform intended to support chain of custody, along with an AI viewer designed to attach metadata to calls, images and videos. Barter said the goal is to reduce both the time required for investigations and the “investigative toil” placed on examiners, detectives and district attorneys.
Barter also highlighted Genesis, a new AI product currently in early access. He said Genesis is built for investigators working with sensitive data, with controls intended to reduce hallucinations. Cellebrite expected about a dozen customers to participate in the early access program, Barter said, but instead drew hundreds of customers and more than 500 participants.
“They’re not just using it to use it,” Barter said. “They’re actually using it to solve crime.” He said the product is expected to launch later this month.
Acquisitions Add New Capabilities
Barter discussed Cellebrite’s acquisition of Corellium, saying its technology provides kernel-level access to ARM-based devices. He said the capability supports vulnerability research, malware inspection and forensic inspection of devices.
An unnamed Cellebrite company representative added that the company’s product portfolio is broader than it was a year ago, citing organic development in products such as Guardian Investigate and Genesis, as well as acquisitions including Corellium and SCG for drone forensics.
Barter said Guardian Investigate is purpose-built for detectives and investigators, with work item tracking, criminal timeline creation and the ability to incorporate Cellebrite’s UFDR mobile extraction files along with other data sources. He said the product is aimed at expanding Cellebrite’s audience beyond forensic examiners to detectives, investigators and district attorneys.
Data Volume and AI Drive Customer Demand
Barter said Cellebrite’s business is being driven by rising data volume and complexity, as well as the need for agencies to compress the investigative life cycle. He said digital investigative capabilities remain underpenetrated even at large federal agencies, including the FBI, and at state-level agencies.
He also emphasized lawful investigations and ethical AI as central to Cellebrite’s operating model. Barter said the company has a strict know-your-customer policy and does not sell “to just anybody” or to every country or customer within a country. He said Cellebrite focuses on customers that are sanctioned or empowered by courts to conduct lawful investigations.
Asked about AI’s impact on Cellebrite, including investor concerns around Mythos, Barter said the company plans a separate technical discussion with its CTO, product leadership and AI leadership. He said Cellebrite has used AI in vulnerability research for years and that its approach centers on engineering trade-offs between hardware and software made by device manufacturers.
The unnamed company representative said Cellebrite views Mythos as “an incremental advance” and “certainly not an existential threat” to the company’s work.
Business Model and Financial Outlook
Barter said Cellebrite has transitioned from selling perpetual licenses years ago to term-based subscriptions for some federal customers and consumption contracts for others. He said the company expects extraction products to represent nearly 80% of revenue this year, down from 90% to 95% historically, with growth products accounting for about 20%.
According to Barter, extraction products continue to grow at “healthy double digits,” while newer products are growing more than 50% year over year and, in some cases, 100% year over year. He said Cellebrite feels good about operating as a “rule of 50” company.
Barter also said Cellebrite is using AI internally in vulnerability research, software development, sales operations, finance and investor relations. He said AI could help the company increase free cash flow margins from above 30% toward 40%.
FedRAMP High Opens Federal Opportunity
Ho asked about Cellebrite’s recent FedRAMP High Authorization, which he said competitors do not have based on William Blair’s understanding. Barter said federal agencies had already been tracking Cellebrite’s progress through the authorization process, adding that the company received an inbound inquiry shortly before receiving its letter.
Barter said the first federal order tied to the authorization could come in the third quarter, though he said timing is uncertain because of government procurement processes.
He said FedRAMP High creates an opportunity for digital transformation in the federal government, particularly for the Department of Justice and for cases involving sensitive data, including internet crimes against children. Barter said Cellebrite sees an opportunity to help federal and state agencies work more efficiently in prosecuting crimes and protecting sensitive evidence.
About Cellebrite DI (NASDAQ:CLBT)
Cellebrite DI is a global provider of digital intelligence and forensics solutions that enable law enforcement agencies, government bodies and enterprises to extract, analyze and act on data from mobile devices, cloud services and digital sources. The company’s technology is designed to accelerate investigations, support evidence-based decision-making and enhance security operations by delivering actionable intelligence in a secure, scalable platform.
The company’s flagship offerings include the Universal Forensic Extraction Device (UFED) series for data acquisition and decoding, Physical Analyzer for advanced data parsing and visualization, and Pathfinder for case-driven investigation workflows.
